Carlson K, Bäcklund L, Smedmyr B, Oberg G, Simonsson B
Department of Internal Medicine, University Hospital, Uppsala, Sweden.
Bone Marrow Transplant. 1994 Nov;14(5):805-11.
Risk factors for early pulmonary complications occurring within the first 3 months after autologous bone marrow transplantation (BMT) were analysed in 158 consecutive adults. The long-term effects of autologous BMT on pulmonary function were analysed in 102 patients, who had survived free of disease for > 6 months after autologous BMT. Pulmonary function tests were performed before, at 6 and 12 months after autologous BMT and thereafter annually. The median follow-up was 12 (6-60) months. The incidence of early pulmonary complications was 16% (26 of 158). Idiopathic interstitial pneumonitis was seen in 11% of patients treated with total body irradiation (TBI). Single dose TBI was the major risk factor as regards early pulmonary complications but restrictive pulmonary disturbances and impaired diffusing capacity prior to autologous BMT were also significant risk factors. In both non-TBI and TBI-treated patients a mild restrictive ventilatory dysfunction and impaired diffusing capacity was noted 6 months after autologous BMT. In non-TBI-treated patients, these disturbances had resolved completely within 2 years whereas the lung volumes of TBI-treated patients were persistently reduced by 10% of their pre-autologous BMT values during follow-up. However, dysfunctions rarely progressed 6 months after autologous BMT. In most patients, ventilatory dysfunction was slight and had no clinical significance.
对158例连续的成年患者分析了自体骨髓移植(BMT)后前3个月内发生早期肺部并发症的危险因素。对102例自体BMT后无病存活超过6个月的患者分析了自体BMT对肺功能的长期影响。在自体BMT前、后6个月和12个月以及此后每年进行肺功能测试。中位随访时间为12(6 - 60)个月。早期肺部并发症的发生率为16%(158例中的26例)。接受全身照射(TBI)的患者中有11%出现特发性间质性肺炎。就早期肺部并发症而言,单次剂量TBI是主要危险因素,但自体BMT前的限制性肺功能障碍和弥散功能受损也是重要危险因素。在非TBI和接受TBI治疗的患者中,自体BMT后6个月均出现轻度限制性通气功能障碍和弥散功能受损。在非TBI治疗的患者中,这些功能障碍在2年内完全缓解,而在随访期间,接受TBI治疗的患者的肺容积持续减少,较自体BMT前的值降低10%。然而,功能障碍在自体BMT后6个月很少进展。在大多数患者中,通气功能障碍轻微,无临床意义。